Adding immunotherapy to chemotherapy plus bevacizumab shows promising benefit in survival for non-epitheliod mesothelioma patients, but not across the board
Read More
JUST PUBLISHED: Phase 2/3 study for sarcomatoid / biphasic mesothelioma
Read More
Pleural Mesothelioma Systemic Treatment, Surgery, Clinical Trials
Read More
Standard chemotherapy plus immunotherapy phase 2 data released, awaiting phase 3 data
Read More
Overview of the mesothelioma program at Mount Sinai in NYC, w/ Dr. Andrea Wolf
Read More
NEWS: Positive results reported from mesothelioma Phase 2/3 trial for sarcomatoid/biphasic patients
Read More